肝脏脂肪变性如何影响二维剪切波弹性成像(2D-SWE.SSI)的诊断效能:从脂肪变性程度和病理类型方面评估
本研究对1306例慢性乙型肝炎患者行2D-SWE.SSI检查并以肝活检为参考标准,发现中重度脂肪变性影响2D-SWE.SSI对≥F2的诊断准确性,F0-1患者中重度脂肪变性组LSM值较高,全腺泡型脂肪变性患者总体诊断效能最高。
要点
- 中重度脂肪变性可影响2D-SWE.SSI对慢性乙型肝炎患者≥F2的诊断准确性。
- F0-1患者中,中重度脂肪变性组LSM值较高。
- 全腺泡型脂肪变性患者2D-SWE.SSI总体诊断效能最高。
核心结论
- 中重度脂肪变性影响慢性乙型肝炎患者2D-SWE.SSI诊断效能,表现为F0-1患者LSM值较高、≥F2诊断准确性较低。
- 全腺泡型脂肪变性患者2D-SWE.SSI总体诊断效能最高。
研究设计与样本
- 对1306例慢性乙型肝炎患者行2D-SWE.SSI检查,以肝活检为参考标准。
- 将患者分为轻度脂肪变性、中重度脂肪变性和无脂肪变性组,并按病理类型进行亚组分析。
- 采用倾向性评分匹配调整患者特征差异,匹配前后用非参数检验比较不同脂肪变性组的中位数,用AUC评估不同脂肪变性组的诊断效能。
诊断标准与关键数值
- 2D-SWE.SSI诊断肝硬化(=F4)的AUC在不同脂肪变性程度间无显著差异(0.896、0.853、0.929,p=0.34)。
- 无脂肪变性组和轻度脂肪变性组对≥F2的AUC较高(0.847、0.856),均显著高于中重度脂肪变性组。
- 全腺泡型脂肪变性患者AUC最佳(F4为0.980,≥F2为0.930)。
临床应用与阅片要点
- 原文结论指出中重度脂肪变性影响2D-SWE.SSI对慢性乙型肝炎患者≥F2的诊断,判读LSM时需结合脂肪变性程度。
- 原文结论指出全腺泡型脂肪变性患者2D-SWE.SSI总体诊断效能最高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Two-dimensional shear wave elastography performed by SurperSonics (2D-SWE.SSI) performs well in evaluating liver fibrosis. Steatosis is one of confounding factors which might decrease accuracy, and its effect on 2D-SWE.SSI is still controversial. Our purpose is to evaluate the diagnostic performance of 2D-SWE.SSI affected by different steatosis stages and pathological types in chronic hepatitis B (CHB) patients.
METHODS: 2D-SWE.SSI was performed on 1306 CHB patients. All patients were divided into mild steatosis, moderate to severe steatosis, and non-steatosis groups. Subgroup analysis was performed according to pathological type. Liver biopsy was reference standard. Propensity score matching was performed to adjust for differences in patient characteristics. The median values of different steatosis group were compared by non-parametric tests before and after propensity score matching. The area under the receiver operating characteristic curve (AUC) was analyzed to assess the diagnostic performance in different steatosis groups.
RESULTS: The median values were not significantly different in different steatosis degrees expected in F0-1 patients. The AUC of 2D-SWE.SSI was not affected by different stages of liver steatosis for cirrhosis (= F4) (0.896, 0.853, 0.929, p = 0.34). The high AUCs (0.847, 0.856) were achieved in the non-steatosis and mild steatosis groups, and all were significantly higher than those of the moderate to severe steatosis group for ≥ F2. Moreover, the panacinar type had the best AUC (0.980 for F4 and 0.930 for ≥ F2).
CONCLUSION: In conclusion, moderate to severe steatosis affects 2D-SWE.SSI in CHB patients. These patients had high LSM values in patients with F0-1 and lower accuracy in ≥ F2. Patients with panacinar steatosis have the highest overall diagnostic performance.
KEY POINTS: • 2D-SWE.SSI was widely used in evaluating liver fibrosis and it has many confounding factors. Steatosis is one of the confounding factors and its effect on 2D-SWE.SSI was controversial. • Our study based on 1306 CHB patients with liver biopsy found that 2D-SWE.SSI might be affected by moderate to severe liver steatosis in diagnostically significant fibrosis (≥ F2) of CHB patients. • Patients with steatosis of the panacinar type have the highest overall diagnostic performance.
引用
- Huang Z, Zhou J, Lu X, et al. How does liver steatosis affect diagnostic performance of 2D-SWE.SSI: assessment from aspects of steatosis degree and pathological types. Eur Radiol. 2020. PMID: 33119813. doi:10.1007/s00330-020-07288-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。